 | • レポートコード：GIR-105X14211 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、遺伝子組換え型チャイニーズハムスター卵巣（CHO）B型肝炎ワクチンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。遺伝子組換え型チャイニーズハムスター卵巣（CHO）B型肝炎ワクチンの種類別市場規模（小児B型肝炎（CHO）ワクチン、成人B型肝炎（CHO）ワクチン）、用途別市場規模（病院、診療所）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・遺伝子組換え型チャイニーズハムスター卵巣（CHO）B型肝炎ワクチンの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Merck & Co., Inc.、GlaxoSmithKline Plc、Pfizer Inc.、Sanofi Pasteur、CSL Limited、Emergent Biosolutions、Serum Institute of India、Johnson & Johnson ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：小児B型肝炎（CHO）ワクチン、成人B型肝炎（CHO）ワクチン ・用途別分析2016年-2026年：病院、診療所 ・遺伝子組換え型チャイニーズハムスター卵巣（CHO）B型肝炎ワクチンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・遺伝子組換え型チャイニーズハムスター卵巣（CHO）B型肝炎ワクチンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・遺伝子組換え型チャイニーズハムスター卵巣（CHO）B型肝炎ワクチンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・遺伝子組換え型チャイニーズハムスター卵巣（CHO）B型肝炎ワクチンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・遺伝子組換え型チャイニーズハムスター卵巣（CHO）B型肝炎ワクチンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Pediatric Hepatitis B (CHO) Vaccine
Adult Hepatitis B (CHO) Vaccine
Market segment by Application can be divided into
Hospitals
Clinics
The key market players for global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine market are listed below:
Merck & Co., Inc.
GlaxoSmithKline Plc
Pfizer Inc.
Sanofi Pasteur
CSL Limited
Emergent Biosolutions
Serum Institute of India
Johnson & Johnson
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Pediatric Hepatitis B (CHO) Vaccine
1.2.3 Adult Hepatitis B (CHO) Vaccine
1.3 Market Analysis by Application
1.3.1 Overview: Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Clinics
1.4 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size & Forecast
1.4.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value (2016-2026))
1.4.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Volume (2016-2026)
1.4.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price by Type (2016-2026) & (USD/Dose)
1.5 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Capacity Analysis
1.5.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Total Production Capacity (2016-2026)
1.5.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Drivers
1.6.2 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Restraints
1.6.3 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Trends Analysis
2 Manufacturers Profiles
2.1 Merck & Co., Inc.
2.1.1 Merck & Co., Inc. Details
2.1.2 Merck & Co., Inc. Major Business
2.1.3 Merck & Co., Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product and Services
2.1.4 Merck & Co., Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 GlaxoSmithKline Plc
2.2.1 GlaxoSmithKline Plc Details
2.2.2 GlaxoSmithKline Plc Major Business
2.2.3 GlaxoSmithKline Plc Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product and Services
2.2.4 GlaxoSmithKline Plc Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Pfizer Inc.
2.3.1 Pfizer Inc. Details
2.3.2 Pfizer Inc. Major Business
2.3.3 Pfizer Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product and Services
2.3.4 Pfizer Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Sanofi Pasteur
2.4.1 Sanofi Pasteur Details
2.4.2 Sanofi Pasteur Major Business
2.4.3 Sanofi Pasteur Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product and Services
2.4.4 Sanofi Pasteur Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 CSL Limited
2.5.1 CSL Limited Details
2.5.2 CSL Limited Major Business
2.5.3 CSL Limited Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product and Services
2.5.4 CSL Limited Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Emergent Biosolutions
2.6.1 Emergent Biosolutions Details
2.6.2 Emergent Biosolutions Major Business
2.6.3 Emergent Biosolutions Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product and Services
2.6.4 Emergent Biosolutions Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Serum Institute of India
2.7.1 Serum Institute of India Details
2.7.2 Serum Institute of India Major Business
2.7.3 Serum Institute of India Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product and Services
2.7.4 Serum Institute of India Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Johnson & Johnson
2.8.1 Johnson & Johnson Details
2.8.2 Johnson & Johnson Major Business
2.8.3 Johnson & Johnson Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product and Services
2.8.4 Johnson & Johnson Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Manufacturer
3.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine
3.4 Market Concentration Rate
3.4.1 Top 3 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Manufacturer Market Share
3.4.2 Top 6 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Manufacturer Market Share
3.5 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Region
4.1.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Volume by Region (2016-2026)
4.1.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Region (2016-2026)
4.2 North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue (2016-2026)
4.3 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue (2016-2026)
4.4 Asia-Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue (2016-2026)
4.5 South America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue (2016-2026)
4.6 Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Volume by Type (2016-2026)
5.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Type (2016-2026)
5.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Volume by Application (2016-2026)
6.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Application (2016-2026)
6.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type (2016-2026)
7.2 North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application (2016-2026)
7.3 North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Country
7.3.1 North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Volume by Country (2016-2026)
7.3.2 North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type (2016-2026)
8.2 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application (2016-2026)
8.3 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Country
8.3.1 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Volume by Country (2016-2026)
8.3.2 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type (2016-2026)
9.2 Asia-Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application (2016-2026)
9.3 Asia-Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Region
9.3.1 Asia-Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type (2016-2026)
10.2 South America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application (2016-2026)
10.3 South America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Country
10.3.1 South America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Volume by Country (2016-2026)
10.3.2 South America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type (2016-2026)
11.2 Middle East & Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application (2016-2026)
11.3 Middle East & Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Country
11.3.1 Middle East & Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Typical Distributors
12.3 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Type, (USD Million), 2021-2026
Table 2. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Application, (USD Million), 2021-2026
Table 3. Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors
Table 4. Merck & Co., Inc. Major Business
Table 5. Merck & Co., Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product and Services
Table 6. Merck & Co., Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. GlaxoSmithKline Plc Basic Information, Manufacturing Base and Competitors
Table 8. GlaxoSmithKline Plc Major Business
Table 9. GlaxoSmithKline Plc Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product and Services
Table 10. GlaxoSmithKline Plc Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 12. Pfizer Inc. Major Business
Table 13. Pfizer Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product and Services
Table 14. Pfizer Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 16. Sanofi Pasteur Major Business
Table 17. Sanofi Pasteur Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product and Services
Table 18. Sanofi Pasteur Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. CSL Limited Basic Information, Manufacturing Base and Competitors
Table 20. CSL Limited Major Business
Table 21. CSL Limited Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product and Services
Table 22. CSL Limited Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Emergent Biosolutions Basic Information, Manufacturing Base and Competitors
Table 24. Emergent Biosolutions Major Business
Table 25. Emergent Biosolutions Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product and Services
Table 26. Emergent Biosolutions Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table 28. Serum Institute of India Major Business
Table 29. Serum Institute of India Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product and Services
Table 30. Serum Institute of India Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 32. Johnson & Johnson Major Business
Table 33. Johnson & Johnson Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product and Services
Table 34. Johnson & Johnson Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Manufacturer (2019-2021e) & (K Doses)
Table 36. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 37. Market Position of Manufacturers in Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 38. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Capacity by Company, (K Doses): 2020 VS 2021
Table 39. Head Office and Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Site of Key Manufacturer
Table 40. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Region (2016-2021e) & (K Doses)
Table 41. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Region (2021-2026) & (K Doses)
Table 42. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Region (2016-2021e) & (USD Million)
Table 43. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Region (2021-2026) & (USD Million)
Table 44. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type (2016-2021e) & (K Doses)
Table 45. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type (2021-2026) & (K Doses)
Table 46. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Type (2016-2021e) & (USD Million)
Table 47. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Type (2021-2026) & (USD Million)
Table 48. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price by Type (2016-2021e) & (USD/Dose)
Table 49. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price by Type (2021-2026) & (USD/Dose)
Table 50. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application (2016-2021e) & (K Doses)
Table 51. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application (2021-2026) & (K Doses)
Table 52. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Application (2016-2021e) & (USD Million)
Table 53. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Application (2021-2026) & (USD Million)
Table 54. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price by Application (2016-2021e) & (USD/Dose)
Table 55. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price by Application (2021-2026) & (USD/Dose)
Table 56. North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2016-2021e) & (K Doses)
Table 57. North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2021-2026) & (K Doses)
Table 58. North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 59. North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 60. North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type (2016-2021e) & (K Doses)
Table 61. North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type (2021-2026) & (K Doses)
Table 62. North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application (2016-2021e) & (K Doses)
Table 63. North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application (2021-2026) & (K Doses)
Table 64. Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2016-2021e) & (K Doses)
Table 65. Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2021-2026) & (K Doses)
Table 66. Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 67. Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 68. Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type (2016-2021e) & (K Doses)
Table 69. Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type (2021-2026) & (K Doses)
Table 70. Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application (2016-2021e) & (K Doses)
Table 71. Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application (2021-2026) & (K Doses)
Table 72. Asia-Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Region (2016-2021e) & (K Doses)
Table 73. Asia-Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Region (2021-2026) & (K Doses)
Table 74. Asia-Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Region (2016-2021e) & (USD Million)
Table 75. Asia-Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Region (2021-2026) & (USD Million)
Table 76. Asia-Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type (2016-2021e) & (K Doses)
Table 77. Asia-Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type (2021-2026) & (K Doses)
Table 78. Asia-Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application (2016-2021e) & (K Doses)
Table 79. Asia-Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application (2021-2026) & (K Doses)
Table 80. South America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2016-2021e) & (K Doses)
Table 81. South America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2021-2026) & (K Doses)
Table 82. South America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 83. South America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 84. South America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type (2016-2021e) & (K Doses)
Table 85. South America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type (2021-2026) & (K Doses)
Table 86. South America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application (2016-2021e) & (K Doses)
Table 87. South America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application (2021-2026) & (K Doses)
Table 88. Middle East & Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2016-2021e) & (K Doses)
Table 89. Middle East & Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2021-2026) & (K Doses)
Table 90. Middle East & Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 91. Middle East & Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 92. Middle East & Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type (2016-2021e) & (K Doses)
Table 93. Middle East & Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type (2021-2026) & (K Doses)
Table 94. Middle East & Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application (2016-2021e) & (K Doses)
Table 95. Middle East & Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application (2021-2026) & (K Doses)
Table 96. Direct Channel Pros & Cons
Table 97. Indirect Channel Pros & Cons
Table 98. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Typical Distributors
Table 99. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Typical Customers
List of Figures
Figure 1. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Picture
Figure 2. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Type in 2020
Figure 3. Pediatric Hepatitis B (CHO) Vaccine
Figure 4. Adult Hepatitis B (CHO) Vaccine
Figure 5. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Application in 2020
Figure 6. Hospitals
Figure 7. Clinics
Figure 8. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size, (USD Million) & (K Doses): 2020 VS 2021 VS 2026
Figure 9. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size and Forecast (2016-2026) & (USD Million)
Figure 10. United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 11. Canada Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Mexico Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Germany Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. France Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. United Kingdom Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Russia Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Italy Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. China Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Japan Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Korea Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. India Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Southeast Asia Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Australia Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Brazil Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Egypt Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Saudi Arabia Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. South Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Turkey Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (2016-2026) & (K Doses)
Figure 30. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Capacity (2016-2026) & (K Doses)
Figure 31. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Capacity by Geographic Region: 2020 VS 2021
Figure 32. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Drivers
Figure 33. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Restraints
Figure 34. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Trends
Figure 35. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Manufacturer in 2020
Figure 36. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Manufacturer in 2020
Figure 37. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 38. Top 3 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Manufacturer (Revenue) Market Share in 2020
Figure 39. Top 6 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Manufacturer (Revenue) Market Share in 2020
Figure 40. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Region (2016-2026)
Figure 41. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Region (2016-2026)
Figure 42. North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue (2016-2026) & (USD Million)
Figure 43. Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue (2016-2026) & (USD Million)
Figure 44. Asia-Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue (2016-2026) & (USD Million)
Figure 45. South America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue (2016-2026) & (USD Million)
Figure 46. Middle East & Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue (2016-2026) & (USD Million)
Figure 47. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Type (2016-2026)
Figure 48. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Type (2016-2026)
Figure 49. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price by Type (2016-2026) & (USD/Dose)
Figure 50. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Application (2016-2026)
Figure 51. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Application (2016-2026)
Figure 52. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price by Application (2016-2026) & (USD/Dose)
Figure 53. North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Country (2016-2026)
Figure 54. North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Country (2016-2026)
Figure 55. North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Type (2016-2026)
Figure 56. North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Application (2016-2026)
Figure 57. Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Country (2016-2026)
Figure 58. Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Country (2016-2026)
Figure 59. Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Type (2016-2026)
Figure 60. Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Application (2016-2026)
Figure 61. Asia-Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Region (2016-2026)
Figure 62. Asia-Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Application (2016-2026)
Figure 65. South America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Country (2016-2026)
Figure 66. South America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Country (2016-2026)
Figure 67. South America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Type (2016-2026)
Figure 68. South America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Application (2016-2026)
Figure 69. Middle East & Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Country (2016-2026)
Figure 70. Middle East & Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Type (2016-2026)
Figure 72. Middle East & Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Application (2016-2026)
Figure 73. Sales Channel: Direct Channel vs Indirect Channel
Figure 74. Methodology
Figure 75. Research Process and Data Source
組換えハムスター卵巣細胞（CHO）B型肝炎ワクチンの世界市場予測 2023年：メーカー別、地域別、種類・用途別 Hepatitis B is a viral infection caused due to transmission of the virus through contact with the blood or other body fluids of an infected person. It is considered as a serious occupational hazard for healthcare professionals, which affects the liver, causing acute and chronic diseases. Hence, Chin…- 世界の遺伝子組換え型B型肝炎ワクチン市場 2021：企業別、地域別、種類・用途別 The Recombinant Hepatitis B Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade…
- 世界の遺伝子組換え型タンパク質ワクチン市場 2021：企業別、地域別、種類・用途別 The Recombinant Protein Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade reg…
- 肝炎治療薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Hepatitis therapeutics are a serial treatment methods targeting on Hepatitis A, Hepatitis B,Hepatitis C and Alcoholic Hepatitis. Scope of the Report: This report studies the Hepatitis Therapeutics market status and outlook of Global and major regions, from angles of players, countries, product types…
- 世界の樹状細胞・腫瘍細胞がんワクチン市場 2021：企業別、地域別、種類・用途別 The Dendritic Cell and Tumor Cell Cancer Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimi…